Rai, Kanti R
Mayo Clinic
Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, NY.
Citations 1
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
Cui, Bing , Ghia, Emanuela M. , Chen, Liguang , Rassenti, Laura Z., DeBoever, Christopher , Widhopf, George F., Yu, Jian , Neuberg, Donna , Wierda, William G. , Kanti, R. , Brown, Jennifer R. , Jones, Jeffrey A. , Frazer, Kelly A. , Neuberg, Donna S , Rai, Kanti R , Kay, Neil E , Frazer, Kelly A , Wierda, William G. , Kay, Neil E. , Gribben, John G. , Kipps, Thomas J.
Blood | November 4, 2016 | Volume: 128 | Issue: 25 | Pages: 2931-2940
Key Points The expression level of ROR1 on CLL cells varies between patients. High-level CLL-cell expression of ROR1 associates with more aggressive disease.